The Discounted Cash Flow (DCF) valuation of Tianjin Lisheng Pharmaceutical Co Ltd (002393.SZ) is 11.78 CNY. With the latest stock price at 19.35 CNY, the upside of Tianjin Lisheng Pharmaceutical Co Ltd based on DCF is -39.1%.
Based on the latest price of 19.35 CNY and our DCF valuation, Tianjin Lisheng Pharmaceutical Co Ltd (002393.SZ) is a sell. selling 002393.SZ stocks now will result in a potential gain of 39.1%.
| Range | Selected | |
| WACC / Discount Rate | 8.3% - 10.7% | 9.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 10.62 - 13.88 | 11.78 |
| Upside | -45.1% - -28.3% | -39.1% |